Tendon / Peripheral Nerve
Even with the best surgical technique, postoperative adhesions can form following tendon and peripheral nerve procedures, including flexor tendon repair, tenolysis, Dupuytren’s contracture, neurolysis, and carpal tunnel syndrome. These adhesions can cause postoperative pain and complications such as limited range of motion. Reduce adhesion formation with Dynavisc® Adhesion Barrier Gel from Fziomed.
Formulated specifically for tendon and peripheral nerve procedures, Dynavisc Adhesion Barrier Gel provides a temporary, protective separation of tissues adjacent to the site of the surgery or procedure during the body’s natural healing process to reduce adhesion formation.
Dynavisc is intended to be placed around soft tissue and neural elements to reduce fibrosis and formation of adhesions following tendon and/or peripheral nerve surgery.
Dynavisc gel is supplied sterile, ready to use in a 1mL syringe with a flexible applicator.
Dynavisc gel is designed to reduce the formation of adhesions that can lead to a limited, often painful reduction in range of motion. Dynavisc gel has been shown in clinical studies to reduce postoperative pain and increase sensory nerve conduction speed.1,2
Clinical Improvements following surgery with the use of Dynavisc for treatment of persistent Carpal Tunnel Syndrome.1
Our patented dual-polymer formulation combines two biocompatible synthetic polymers proven safe and effective over more than two decades of use worldwide. Dynavisc gel is absorbable and contains no pharmaceutical agents or materials of human, animal, or bacterial origin.
Dynavisc gel is provided sterile, ready to use, and requires no mixing or special handling or storage conditions. The prepackaged, thin flexible applicator allows for ease of application, while the clear absorbable gel maintains operative site visibility.
Reducing postoperative pain and adhesiogenic complications such as joint stiffness or diminished mobility can lead to improved patient satisfaction and outcomes, minimizing potential risks in future operations and patient complaints.
Dynavisc gel’s unique viscosity is flowable yet remains where applied with no change in volume that could adversely affect nearby tissues and nerves.
Contact us for additional information or to inquire about product availability in your country.
Fziomed, Inc.
231 Bonetti Drive
San Luis Obispo, CA 93401
USA
Phone: +1 (805) 546-0610
Fax: +1 (805) 546-0571
Email: [email protected]
Fziomed products are not currently available in the United States.
The following trademarks are owned by Fziomed, Inc. and registered in the United States and certain foreign jurisdictions: FZIOMED®, OXIPLEX®, OXIPLEX/SP®, DYNAVISC®, INTERPOSE®, INTERCOAT®, OXIPLEX/AP®, and OXIPLEX/IU®.
Website design RainCastle Communications.
Last update: Feb. 25, 2025
